Precision BioSciences Inc (DTIL)
9.82
-0.41
(-4.01%)
USD |
NASDAQ |
Apr 24, 16:00
9.82
0.00 (0.00%)
After-Hours: 20:00
Precision BioSciences Free Cash Flow: -86.39M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | -86.39M |
| September 30, 2023 | -100.45M |
| June 30, 2023 | -48.82M |
| March 31, 2023 | -51.57M |
| December 31, 2022 | -49.07M |
| September 30, 2022 | -51.78M |
| June 30, 2022 | -105.27M |
| March 31, 2022 | -113.29M |
| December 31, 2021 | -16.66M |
| September 30, 2021 | -6.018M |
| June 30, 2021 | -3.90M |
| Date | Value |
|---|---|
| March 31, 2021 | 1.543M |
| December 31, 2020 | -92.42M |
| September 30, 2020 | -103.95M |
| June 30, 2020 | -100.58M |
| March 31, 2020 | -97.70M |
| December 31, 2019 | -95.68M |
| September 30, 2019 | -92.38M |
| June 30, 2019 | -91.59M |
| March 31, 2019 | -77.32M |
| December 31, 2018 | -67.40M |
Free Cash Flow Range, Past 5 Years
-113.29M
Minimum
Mar 2022
1.543M
Maximum
Mar 2021
-68.74M
Average
-91.59M
Median
Jun 2019
Free Cash Flow Benchmarks
| Altimmune Inc | -75.86M |
| BioVie Inc | -41.11M |
| Adial Pharmaceuticals Inc | -6.807M |
| Gritstone Bio Inc | -126.22M |
| Humacyte Inc | -75.58M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -8.423M |
| Cash from Investing (Quarterly) | 0.042M |
| Cash from Financing (Quarterly) | 2.828M |
| Free Cash Flow Per Share (Quarterly) | -2.022 |
| Free Cash Flow to Equity (Quarterly) | -8.465M |
| Free Cash Flow Yield | -226.8% |